Perspective Therapeutics (CATX) Gross Margin Growth (1y) (2011 - 2023)
Perspective Therapeutics (CATX) Gross Margin Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -65.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 610.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -359.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -522.00 |
| Jun 30, 2023 | -2,718.00 |
| Mar 31, 2023 | -2,591.00 |
| Sep 30, 2022 | -114.00 |
| Jun 30, 2022 | -596.00 |
| Mar 31, 2022 | -287.00 |
| Dec 31, 2021 | -615.00 |
| Sep 30, 2021 | -1,213.00 |
| Jun 30, 2021 | 267.00 |
| Mar 31, 2021 | -685.00 |
| Dec 31, 2020 | -89.00 |
| Sep 30, 2020 | -113.00 |
| Jun 30, 2020 | 131.00 |
| Mar 31, 2020 | 1,355.00 |
| Dec 31, 2019 | 1,018.00 |
| Sep 30, 2019 | 1,984.00 |
| Jun 30, 2019 | 1,805.00 |
| Mar 31, 2019 | 697.00 |
| Dec 31, 2018 | 561.00 |
| Sep 30, 2018 | 1,166.00 |